Navigation Links
TAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System

ProductsTAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System
Company Boston Scientific Corporation
Item TAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System
Features A Proven Stent
The Express Stent platform offers excellent deliverability and conformability.
  • Excellent deliverability allows for treatment of a variety of patient and lesion types.
  • Excellent conformability allows the stent to mold to the natural contours of the vessel wall.
  • Broad working range facilitates precise deployment and sizing flexibility, making it easy to achieve full stent apposition.
    • A Reliable Polymer
    The TAXUS stent uses Translute Polymer, a proprietary polymer carrier technology, to control drug release.
  • he durable Translute Polymer protects the drug and maintains coating integrity during preparation, delivery, and stent expansion.
  • The polymer controls the release of paclitaxel, which may allow for consistent drug release and more uniform drug distribution.
    • An Effective Drug
    The unique properties of paclitaxel may contribute to the efficacy of the TAXUS Stent.
  • Paclitaxel's multi-functional effects, stabilize microtubules and inhibit activities that contribute to restenosis.
  • Paclitaxel is highly lipophilic, which may contribute to more uniform drug distribution.
  • At the dose used in the TA
    • Description The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3.75 mm in diameter.
    Info Boston Scientific Corporation
    Customer Service: (888) 272-1001
    Web site: http://www.bostonscientific.com

    Related medicine products :

    1. TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System
    2. NIR Elite Monorail Stent System
    3. Cutting Balloon Ultra2 Monorail Platform
    4. Atlantis SR Pro Coronary Imaging Catheter
    5. Cypher Sirolimus-eluting Coronary Stent
    6. MULTI-LINK OTW PIXEL Coronary Stent System
    7. MULTI-LINK RX PIXEL Coronary Stent System
    8. Express Coronary Stent System
    9. S660 with Discrete Technology Coronary Stent System
    10. MULTI-LINK OTW ZETA Coronary Stent System
    11. MULTI-LINK OTW PENTA Coronary Stent System
    Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Acute Lymphoblastic Leukemia the Most Common Childhood Cancer Is Curable Without Preventive Cranial Radiation 4644 1Acute Lymphoblastic Leukemia the Most Common Childhood Cancer Is Curable Without Preventive Cranial Radiation 4644 2Acute Lymphoblastic Leukemia the Most Common Childhood Cancer Is Curable Without Preventive Cranial Radiation 4644 3Acute Lymphoblastic Leukemia the Most Common Childhood Cancer Is Curable Without Preventive Cranial Radiation 4644 4Migraine Frequency Tied to Stroke Heart Attack Risk 49976 1Migraine Frequency Tied to Stroke Heart Attack Risk 49976 2Migraine Frequency Tied to Stroke Heart Attack Risk 49976 3New Cancer Drug Fights Tumors in Those With BRCA Mutations 49974 1New Cancer Drug Fights Tumors in Those With BRCA Mutations 49974 2New Cancer Drug Fights Tumors in Those With BRCA Mutations 49974 3